Login / Signup

Influence of Parent-of-Origin on Intellectual Outcomes in the Chromosome 22q11.2 Deletion Syndrome.

Daniel E McGinnTerrence Blaine CrowleyTracy HeungOanh TranEdward MossElaine H ZackaiBeverly S EmanuelEva W C ChowBernice E MorrowAnn SwillenAnne Susan BassettDonna M McDonald-McGinn
Published in: Genes (2022)
Learning and intellectual disabilities are hallmark features of 22q11.2 deletion syndrome. Data are limited, however, regarding influences on full-scale IQ (FSIQ). Here, we investigated possible 22q11.2 deletion parent-of-origin effects. In 535 individuals, we compared FSIQ (≥50), 481 with de novo and 54 with inherited 22q11.2 deletions. In the subsets with data available, we examined parent-of-origin effects on FSIQ. We used linear regression models to account for covariates. Median FSIQ was significantly higher in de novo vs. inherited deletions (77; range 50-116 vs. 67; range 50-96, p < 0.0001). Results remained significant using a regression model accounting for age at IQ testing, sex and cohort site. No significant parent-of-origin differences in FSIQ were observed for de novo deletions (n = 81, 63.0% maternal; p = 0.6882). However, median FSIQ was significantly lower in maternally than in paternally inherited familial deletions (65, range 50-86 vs. 71.5, range 58-96, respectively, p = 0.0350), with the regression model indicating an ~8 point decrement in FSIQ for this variable ( p = 0.0061). FSIQ is higher on average in de novo than in inherited 22q11.2 deletions, regardless of parental origin. However, parent-of-origin appears relevant in inherited deletions. The results have potential clinical implications with further research needed to delineate possible actionable mechanisms.
Keyphrases
  • electronic health record
  • case report
  • big data
  • metabolic syndrome
  • adipose tissue
  • early onset
  • machine learning
  • risk assessment
  • climate change
  • dna methylation
  • peripheral blood
  • mass spectrometry
  • high resolution